Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Pathology & Oncology Research
Published in: Pathology & Oncology Research 3/2008

01-09-2008 | Brief Communication

Malignant Peripheral Nerve Sheath Tumor of the Liver: A Case Report

Authors: László Kóbori, Péter Nagy, Zoltán Máthé, Erika Hartmann, Attila Doros, Sándor Paku, Katalin Dezső, Zoltán Sápi

Published in: Pathology & Oncology Research | Issue 3/2008

Login to get access

Abstract

A large, rapidly growing malignant peripheral nerve sheath tumor (MPNST) of the liver in a young female patient, not associated with von Recklinghausen’s disease, is presented. Diagnosis was based on detailed immunohistochemical and electromicroscopic examination beside the characteristic H&E picture. As far as we know, this is the first reported, unambiguously proven “de novo” MPNST in the liver. Differential diagnostic problems are discussed and a review of the literature is given.
Literature
1.
Schmurun RI, Chibisov VN (1977) Malignant neurinoma of the liver. Ark Pathol 39:69–71
2.
Young SJ (1975) Primary malignant neurilemmoma (schwannoma) of the liver in a case of neurofibromatosis. J Pathol 117:151–153CrossRefPubMed
3.
Lederman SM, Martin EC, Laffey KT, Lefkowitch JH (1987) Hepatic neurofibromatosis, malignant schwannoma, and angiosarcoma in von Recklinghausen’s disease. Gastroenterology 92:234–239PubMed
4.
Scheithauer BW, Woodruff JM, Erlandson RA (1999) Primary malignant tumors of peripheral nerve In Atlas of tumor pathology: Tumors of the Peripheral nervous system, Third Series, Fascicle 24 Washington, DC, Armed Forsis Institute of Pathology, pp 303–310
5.
6.
Kiani B, Ferrell LD, Qualman S, Frankel WL (2006) Immunohistochemical analysis of embryonal sarcoma of the liver. Appl Immunohistochem Mol Morphol 14:193–197CrossRefPubMed
7.
Walker NI, Horn MJ, Strong RW, Lynch SV, Cohen J, Ong TH, Harris OD (1992) Undifferentiated (embryonal) sarcoma of the liver. Cancer 69:52–59CrossRefPubMed
8.
Fiel MI, Schwarz M, Min AD, Sung MW, Thung SN (1996) Malignant schwannoma of the liver in a patient without neurofibromatosis. Arch Pathol Lab Med 120:1145–1147PubMed
9.
Morikawa Y, Ishihara Y, Matsuura N (1995) Malignant schwannoma of the liver. Dig Dis Sci 40:1279–1282CrossRefPubMed
10.
Yoshida M, Nakashima Y, Tanaka A, Mori K, Yamaoka Y (1994) Benign schwannoma of the liver: a case report. Arch Jpn Chir 63:208–214
11.
Hytiroglou P, Linton P, Klion F, Schwartz M, Miller C, Thung SN (1993) Benign schwannoma of the liver. Arch Pathol Lab Med 117:216–218PubMed
12.
Heffron TG, Coventry S, Bedendo F, Baker A (1993) Resection of primary schwannoma of the liver not associated with neurofibromatosis. Arch Surg 128:1396–1398PubMed
13.
Tuder RM, Moraes CF (1984) Primary semimalignant schwannoma of the liver: light and electron microscopic studies. Pathol Res Pract 178:345–348PubMed
14.
Woodruff JM, Selig AM, Crowley K, Allen PW (1994) Schwannoma (neurilemmoma) with malignant transformation. Am J Surg Pathol 18:882–895PubMedCrossRef
Metadata
Title
Malignant Peripheral Nerve Sheath Tumor of the Liver: A Case Report
Authors
László Kóbori
Péter Nagy
Zoltán Máthé
Erika Hartmann
Attila Doros
Sándor Paku
Katalin Dezső
Zoltán Sápi
Publication date
01-09-2008
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 3/2008
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-008-9078-0

Other articles of this Issue 3/2008

Pathology & Oncology Research 3/2008 Go to the issue

Original Paper

Bcl-2 Antisense Oligonucleotide Inhibits the Proliferation of Childhood Leukemia/lymphoma Cells of the B-cell Lineage

Original Paper

K-ras Mutation, HPV Infection and Smoking or Alcohol Abuse Positively Correlate with Esophageal Squamous Carcinoma

Original Paper

Practice of HER-2 Immunohistochemistry in Breast Carcinoma in Austria

Original Paper

Comparison of Virtual and Fiberoptic Bronchoscopy in the Management of Airway Stenosis

Original Paper

Focal Lymphoid Hyperplasia of the Terminal Ileum Presenting Mantle Zone Hyperplasia with Clear Cytoplasm. A Report of Three Cases

Review

Extracellular ATP and Cancer—An Overview with Special Reference to P2 Purinergic Receptors
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits